Pharmacy practice management quarterly最新文献

筛选
英文 中文
Improving warfarin anticoagulation therapy in a community health system. 改善社区卫生系统中的华法林抗凝治疗。
M J Pubentz, D E Calcagno, J L Teeters
{"title":"Improving warfarin anticoagulation therapy in a community health system.","authors":"M J Pubentz,&nbsp;D E Calcagno,&nbsp;J L Teeters","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>An internal chart review of warfarin patients revealed a 44 percent complication rate resulting in higher treatment costs, and identified patient noncompliance, access to monitoring, and insufficient patient education as contributing factors. A warfarin usage guideline was created to assist physicians with warfarin management and subsequently the Anticoagulation Center (ACC) was established. To date over 950 patients have been managed through the ACC with therapeutic international normalized ratios an average of 82 percent of the time. Fewer bleeds and treatment failures have occurred in the ACC group, and a patient satisfaction survey revealed that ACC patients were very satisfied with their care more often than non-ACC patients.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 3","pages":"1-16"},"PeriodicalIF":0.0,"publicationDate":"1998-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21057074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacy alternative futures. 药房替代期货。
W E Smith
{"title":"Pharmacy alternative futures.","authors":"W E Smith","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 2","pages":"37-47"},"PeriodicalIF":0.0,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21057272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing and implementing oral 5-HT3 receptor antagonist guidelines: a multidisciplinary process. 制定和实施口服5-HT3受体拮抗剂指南:一个多学科的过程。
S S Rough, G W Carro
{"title":"Developing and implementing oral 5-HT3 receptor antagonist guidelines: a multidisciplinary process.","authors":"S S Rough,&nbsp;G W Carro","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 2","pages":"48-58"},"PeriodicalIF":0.0,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21057273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services. 重整零售/流动药房,以提供生物科技药剂服务。
P J Schneider
{"title":"Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.","authors":"P J Schneider","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 2","pages":"32-6"},"PeriodicalIF":0.0,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21057271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Designer drugs: the evolving science of drug discovery. 设计药物:不断发展的药物发现科学。
L A Wanke, R F DuBose
{"title":"Designer drugs: the evolving science of drug discovery.","authors":"L A Wanke,&nbsp;R F DuBose","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Drug discovery and design are fundamental to drug development. Until recently, most drugs were discovered through random screening or developed through molecular modification. New technologies are revolutionizing this phase of drug development. Rational drug design, using powerful computers and computational chemistry and employing X-ray crystallography, nuclear magnetic resonance spectroscopy, and three-dimensional quantitative structure activity relationship analysis, is creating highly specific, biologically active molecules by virtual reality modeling. Sophisticated screening technologies are eliminating all but the most active lead compounds. These new technologies promise more efficacious, safe, and cost-effective medications, while minimizing drug development time and maximizing profits.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 2","pages":"13-22"},"PeriodicalIF":0.0,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21057269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice. 生物技术:概述工具、治疗药物和在药学实践中的应用。
P Piascik
{"title":"Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice.","authors":"P Piascik","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The promise of pharmaceutical biotechnology and its applications to health care is now being realized. Over 30 therapeutic agents produced by the tools of biotechnology are now available and nearly 300 more are in various stages of development. Recombinant proteins, monoclonal antibodies, gene therapy, and vaccines can provide effective treatments and cures for diseases we could only mitigate in the past. The availability of these drugs presents several interesting challenges and opportunities to pharmacists. The expense, complexity, and unique properties of biotechnology agents will continue to alter not only the knowledge base of pharmacy but also the way pharmacists perform their professional responsibilities.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 2","pages":"1-12"},"PeriodicalIF":0.0,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21057268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The pharmacoeconomics of high-cost biotechnology products. 高成本生物技术产品的药物经济学。
W J Dana, K Farthing
{"title":"The pharmacoeconomics of high-cost biotechnology products.","authors":"W J Dana,&nbsp;K Farthing","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Biotechnology products have created therapy options in areas that have been historically limited. These improvements in patient care have resulted in a reappraisal of the emphasis placed on product acquisition costs and a movement toward evaluating the impact of the product on the entire health care system. Strategic planning for biotechnology products allows pharmacists to partner with the medical staff and financial/administrative representatives of the institution to measure clinical outcomes, estimate cost and revenue impact, document utilization, and promote cost-effective use of these new therapies to generate the maximum benefit for dollars expended.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 2","pages":"23-31"},"PeriodicalIF":0.0,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21057270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons learned in managed care. 管理式医疗的经验教训。
J B Burl
{"title":"Lessons learned in managed care.","authors":"J B Burl","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Competition, reduction in health care premiums, rising health care costs, aging of the population, and technologic advances are several factors that create both challenges and opportunities for managed care organizations (MCOs). The demands to constantly improve quality of care and efficiency of operation while holding down costs are drivers meant to stimulate organizations to constantly strive to rethink their process of care provision. The most cost-effective program is one that maintains its health plan members who are active in the community and away from the institutional setting. This is optimally achieved through an accessible and comprehensive ambulatory practice. Innovation and paradigms of practice change in the acute, subacute, and long-term care arenas have allowed us to dramatically impact quality and utilization in these expensive areas, while at the same time freeing up additional time for MCO primary care practitioners to focus on their community-based patients. MCO primary care providers have not only supported but welcomed these changes in their organization, recognizing that these innovations represent a component of the continuum of health care needed to effectively serve their patients.</p>","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 2","pages":"59-66"},"PeriodicalIF":0.0,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21057274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing a management planning and control system for ambulatory pharmacy resources. 建立门诊药房资源管理计划与控制系统。
V S Crane, C A Hatwig, J N Hayman, R Hoffman
{"title":"Developing a management planning and control system for ambulatory pharmacy resources.","authors":"V S Crane,&nbsp;C A Hatwig,&nbsp;J N Hayman,&nbsp;R Hoffman","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 1","pages":"52-71"},"PeriodicalIF":0.0,"publicationDate":"1998-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21049143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disease management and business alliances. 疾病管理和商业联盟。
B A Russell, K M Patneau, L Tremonti
{"title":"Disease management and business alliances.","authors":"B A Russell,&nbsp;K M Patneau,&nbsp;L Tremonti","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80126,"journal":{"name":"Pharmacy practice management quarterly","volume":"18 1","pages":"81-9"},"PeriodicalIF":0.0,"publicationDate":"1998-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21049149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信